References, State of the Evidence 2010
Scientific references from State of the Evidence: The Connection Between Breast Cancer and the Environment (sixth edition, 2010), by Janet Gray, Ph.D. Parenthetical references from the document text and select science pages of our Web site are listed here in alphabetical order.
A B C D E F G H I J K L M
N O P Q R S T U V W X Y Z
A
Acevedo R, Parnell PG, Villanueva H, et al. (2005). The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency. J Appl Toxicol, 25:339-353.
ACS: American Cancer Society (2009). Breast Cancer Facts & Figures 2009-2010. Atlanta: American Cancer Society, Inc.
Adam A, Bardo H, Adany R (2005). Increased genotoxic susceptibility of breast epithelial cells to ethylene oxide. Mutation Res, 585:120-126.
Adams MJ, Dozier A, Shore RE, et al. (2010). Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today. Cancer Epidemiol Biomarkers Prev, 19:48-58.
Adlercreutz H (2003). Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol, 83:113-118.
AdvaMed (2009). Medical devices and articles used in product manufacturing containing bisphenol-a related materials. www.thegraysheet.com/nr/FDC/SupportingDocs/gray/2009/011209_AdvaMed_BPA_chart.pdf (7/12/2010).
Ahlbom A, Cardis E, Green A, et al. (2001). Review of the epidemiological literature on MF and health. Environ Health Perspect, 109 (Suppl 6):911-933.
Aksglaede L, Juul A, Leffers H, Skakkebaek NE, Andersson AM (2006). The sensitivity of the child to sex steroids: possible impact of exogenous estrogens. Hum Reprod Update, 12:341-349.
Al-Dobaib SN, Mousa HM (2009). Benefits and risks of growth promoters in animal production. J Food Agric Environ, 7:202-208.
Alexander BH, Mandel JS, Baker BA, et al. (2007). Biomonitoring of 2,4-dichlorophenoxyacetic acid exposure and dose in farm families. Environ Health Perspect, 115:370-376.
Allen NE, Roddam AW, Allen DS, et al. (2005). A prospective study of serum insulin-like growth factor-I (IGF-1), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer, 92:1283-1287.
Allmyr M et al. (2006). Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ, 372:87-93.
Althuis MD, Brogan DD, Coates RJ, et al. (2003). Breast cancers among very young premenopausal women (United States). Cancer, Causes Control, 14:151-160.
Althuis MD, Dozier JM, Anderson WF, et al. (2005). Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol, 34:405-412.
Altman RG, Morello-Frosch R, Brody JG, et al. (2008). Pollution comes home and gets personal: Women’s experience of household chemical exposure. J Health Soc Behav, 49:417-434.
Ambrosone CB, Freudenheim JL, Graham S, et al. (1996). Cigarette smoking, N-acetyltransferase 2 polymorphisms, and breast cancer risk. J Am Med Assoc, 276:1494-1501.
Andersen HR, Vinggaard AM, Rasmussen TH, et al. (2002). Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol, 179:1-12.
Anderson GL, Limacher M (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled study. J Am Med Assoc, 291:1701-1712.
Anderson HA, Wolff MS (2000). Environmental contaminants in human milk. J Expos Anal Environ Epidemiol, 10 (II Suppl.):755-760.
Anderson WF, Matsuno RK, Sherman ME, et al. (2007). Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control, 18:439-447.
Andersson PL, Blom A, Johannisson A, et al. (1999). Assessment of PCBs and hydroxylated PCBs as potential xenoestrogens: In vitro studies based on MCF-7 cell proliferation and induction of vitellogenin in primary culture of rainbow trout hepatocytes. Arch Environ Contam Toxicol, 37:145-150.
Andersson TML, Johansson ALV, Hsieh CC, et al. (2009). Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol, 114:568-572.
Andreeva VA, Unger JB, Pentz MA (2007). Breast cancer among immigrants: a systematic review and new research directions. J Immigrant Minor, 9:307-322.
Andrieu N, Easton DF, Chang-Claud J, et al. (2006). Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study: A report from EMBRACE, GEGNNEPSO, GEO-HEBON, and IBCCS Collaborators’ Group. J Clin Oncol, 24:3361-3366.
Angerer J, Bird MG, Burke TA, et al. (2006). Strategic biomonitoring initiatives: Moving the science forward. Toxicol Sci, 93:3-10.
Antoniou CV, Koukouraki EE, Diamadopoulos E (2009). Analysis of selected pharmaceutical compounds and endocrine disruptors in municipal wastewater using solid-phase microextraction and gas chromatography. Water Environ Res, 81:664-669.
Arnold SF, Klotz DM, Collins BM, et al. (1996). Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science, 272:1489-1492.
Aronson KJ, Miller AB, Woolcott CG, et al. (2000). Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 9:55-63.
Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, et al. (2006). Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev, 15:2123-2130.
Athar M, Back JH, Kopelovich L, et al. (2009). Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys, 486:95-102.
ATSDR: Agency for Toxic Substances and Disease Registry (1996). ToxFAQs for vinyl chloride. www.atsdr.cdc.gov/toxprofiles/tp20.html (7/12/2010).
ATSDR: Agency for Toxic Substances and Disease Registry (1999). ToxFAQs for ethylene oxide. www.atsdr.cdc.gov/toxfaqs/TF.asp?id=733&tid=133 (7/12/2010).
ATSDR, Agency for Toxic Substances and Disease Registry (1999). ToxFAQs for chlorinated dibenzo-p-dioxins. www.atsdr.cdc.gov/toxfaqs/TF.asp?id=363&tid=63 (7/12/2010).
ATSDR: Agency for Toxic Substances and Disease Registry Fact Sheet (2010). ToxFAQs for aldrin/dieldrin. www.atsdr.cdc.gov/tfacts1.html (7/12/2010).
B
Baccarelli A, Bollati V (2009). Epigenetics and environmental chemicals. Curr Opin Pediatr, 21:243-251.
Ballard T, Lagorio S, De Angelis G, et al. (2000). Cancer incidence and mortality among flight personnel: A meta-analysis. Aviat Space Environ Med, 71:216-224.
Balmain A, Harris CC (2000). Carcinogenesis, in mouse and human cells: parallels and paradoxes. Carcinogenesis, 21:371-377.
Band PR, Le ND, Fang R et al. (2002). Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet, 360:1033-1034.
Barcellos-Hoff MH, Park C, Wright EG (2005). Radiation and the microenvironment: Tumorogenesis and therapy. Nat Rev Cancer, 5:867-875.
Barlow BK, Cory-Slechta DA, Richfield EK, et al. (2007). The gestational environment and Parkinson’s disease: Evidence for neurodevelopmental origins of a neurodegenerative disease. Reprod Toxicol, 23: 457-470.
Bauer KR, Brown M, Cress RD, et al. (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry. Cancer, 109:1721-1728.
BCERC: Breast Cancer and the Environment Research Centers (2010). BCERC research. www.bcerc.org/research.htm (7/12/2010).
Beard J (2006). DDT and human health. Sci Total Environ, 355:78-89.
Belli S, Comba P, De Santis M, et al. (1992). Mortality study of workers employed by the Italian National Institute of Health, 1960-1989. Scand J Work Environ Health, 18:64-67.
Benbrahim-Tallaa L, Tokar EJ, Diwan BA, et al. (2009). Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect, 117:1847-1852.
Bennett M, Davis BJ (2002). The identification of mammary carcinogens in rodent bioassays. Environ Mol Mutagenesis, 39:150-157.
Benotti MJ, Trenholm RA, Vanderford BJ, et al. (2009). Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol, 43:597-603.
Benzoni E, Minervini F, Giannoccaro A, et al. (2008). Influence of in vitro exposure to mycotoxin zearalenone and its derivatives on swine sperm quality. Reprod Toxicol, 25: 461-467.
Bernstein L, Allen M, Anton-Culver H, et al. (2002). High breast cancer incidence rates among California teachers: Results from the California Teachers Study (United States). Cancer Causes Control, 13:625-635.
Berrington de Gonzalez A, Berg C, Visvanathan K, Robson M (2009a). Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst, 101:205-209.
Berrington de Gonzalez A, Mahesh M, Kim K-P et al. (2009b). Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med, 169:2071-2077.
Beyea J, Stellman SD, Hatch M, Gammon MD (2008). Airborne emissions from 1961 to 2004 of benzo(a)pyrene from U.S. vehicles per km of travel based on tunnel studies. Environ Sci Technol, 47:7315-7320.
Bhatia S, Yasui Y, Robison LL, et al.: Late Effects Study Group (2003). High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol, 21:4386-94.
Bhatti P, Doody MM, Alexander BH, et al., (2007). Breast cancer risk polymorphisms and interactions with ionizing radiation among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev, 17:2007-2011.
Bibbo M, Gill WB, Azizi F, et al. (1977). Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol J, 49:1-8.
Biglia N, Sgro L, Defabiani E, et al. (2005). The influence of hormone replacement therapy on the pathology of breast cancer. EJSO: J Cancer Surg, 31:467-472.
Birnbaum LS (2009). Halogenated flame retardants: Does the benefit justify the risk? Keynote address: 6th Annual Early Enviornmental Exposures Conference of the Breast Cancer and the Environment Research Centers, Sausalito, CA.
Birnbaum LS, Fenton SE (2003). Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect, 111: 389-394.
Blask DE, Brainard GC, Dauchy RT, et al. (2005). Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res, 65:11174-11184.
Blask DE (2009). Melatonin, sleep disturbance and cancer risk. Sleep Med Rev, 13:257-264.
Boice JD (2001). Radiation and breast carcinogenesis. Med & Pediatr Oncol, 36:508-513.
BOLS: Bureau of Labor Statistics (2005). Table 11. Employed Persons by Detailed Occupation, Sex, Race, and Hispanic or Latino ethnicity, age 16 years or older.
Bonner MR, Han D, Nie J, et al. (2005). Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev, 14:53-60.
Borch J, Axelstad M, Vinggaard AM, et al. (2006). Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicol, 223:144-155.
Borgquist S, Anagnostaki L, Jirstom K, et al. (2007). Breast tumours following combined hormone replacement therapy express favorable prognostic factors. Int J Cancer, 120:2202-2207.
Borrell B. (2010). The big test for bisphenol A. Nature, 464:1122-1124.
Boucher BA, Cotterchio M, Krieger N, Thompson L (2008). Soy formula and breast cancer risk. Epidemiology, 19:165-168.
Bourguignon J-P, Rasier G, Lebrethon M-C, et al. (2010). Neuroendocrine disruption of pubertal timing and interactions between homeostasis of reproduction and energy balance. Mol Cell Endocrinol, 324:110-120.
Bowen RL, Stebbing J, Jones LJ (2006). A review of the ethnic differences in breast cancer. Pharmacogenomics 7:935-942.
Braathen M, Mortensen AS, Sandvik M, et al. (2009). Estrogenic effects of selected hydroxy polychlorinated biphenyl congeners in primary culture of Atlantic salmon (Salmo salar) hepatocytes. Arch Environ Contam Toxicol 56:111-122.
Bradbury AR, Olopade OI (2007). Genetic susceptibility to breast cancer. Rev Endocr Metab Disord, 8:255-267.
Bradley EL, Boughtflower V, Smith TL, et al. (2005). Survey of the migration of melamine and formaldehyde from melamine food contact articles available on the UK market. Food Addit Contam. 22:597-606.
Brama M, Gnessi L, Basciani S, et al. (2007). Cadmium induces mitogenic signaling in breast cancer cell by an Eralpha-dependent mechanism. Mol Cell Endocrinol, 264:102-108.
Brand RM, McMahon L, Jendrzejewski JL, et al. (2007). Transdermal absorption of the herbicide 2,4-dichlorophenoxyacetic acid is enhanced by both ethanol consumption and sunscreen application. Food Chem Toxicol, 45:93-97.
Braun JM, Yolton K, Dietrich KN, et al. (2009). Prenatal bisphenol A exposure and early childhood behavior. Environ Health Perspect, 117:1945-1952.
Brenner DJ, Doll R, Goodhead DT, et al. (2003). Cancer risks attributable to low doses of ionizing radiation. Proc Natl Acad Sci, 100 (24):13761-13766.
Brinton LA, Scoccia B, Moghissi KS, et al. (2004). Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod, 19:2005-2013.
Brody JG, Rudel RA, Melly SJ, et al. (1998). Endocrine disruptors and breast cancer. Forum Appl Res Public Policy, 13:24-31.
Brody JG, Rudel RA (2003). Environmental pollutants and breast cancer. Environ Health Perspect 111:1007-1009.
Brody JG, Aschengrau A, McKelvey W, et al. (2004). Breast cancer risk and historical exposure to pesticides from wide-area applications assessed with GIS. Environ Health Perspect, 112:889-897.
Brody JG, Moysich KB, Humblet O, et al. (2007). Environmental pollutants and breast cancer. Epidemiol Stud Cancer, 109 (S12):2667-2711.
Brody JG, Morello-Frosch R, Zota A, et al. (2009). Linking exposure assessment science with policy objectives for environmental justice and breast cancer advocacy: The Northern California Household Exposure Study. Am J Public Health, 99:S600-S609.
Bronaugh RL, Collier SW, Macpherson SE, et al. (1994). Influence of metabolism in skin on dosimetry after topical exposure. Environ Health Perspect 102(S11):71-74.
Brophy JT, Keith MM, Gorey KM, et al. (2006). Occupation and breast cancer: A Canadian case-control study. Ann NY Acad Sci, 1076:765-777.
Brotons JA, Olea-Serrano MF, Villalobos M, et al. (1995). Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect, 103:608-612.
Brown NM, Manzolillo PA, Zhang JX, et al. (1998). Prenatal TCDD and predisposition to mammary cancer in rats. Carcinogenesis, 19:1623-1629.
Brulle RJ, Pellow DN (2006). Environmental justice: human health and environmental inequalities. Ann Rev Public Health, 27:103-124.
Bruner Huber LR, Huber KR (2009). Contraceptive choices of women 35-44 years of age: Findings from the behavioral risk factor surveillance system. Ann Epidemiol, 19:823-833.
Byford JR, Shaw LE, Drew MGB, et al. (2002). Oestrogenic activity of parabens in MCF7 human breast cancer cells, J Steroid Biochem Mol Biol, 80:49-60.
Byrne C, Divekar SD, Storchan GB, et al. (2009). Cadmium: a metallohormone? Toxicol Appl Pharmacol, 238:266-271.
C
Calabrese EJ (2004). Hormesis: from marginalization to mainstream. A case for hormesis as the default dose-response model in risk assessment. Toxicol Pharmacol, 197:125-136.
Calabrese EJ, Staudenmayer JW, Stanek EJ, Hoffmann GR (2006). Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database, Toxicol Sci, 94:368-378.
Calaf GM, Hei TK (2000). Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis, 21:769-776.
Calafat AM, Kuklenyik Z, Reidy JA, et al. (2005). Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect, 113:391-395.
Calafat AM, Ye X, Wong L-Y, Reidy JA, Needham LL. (2008). Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect, 116:39-44.
Calafat AM, Weuve J, Ye X, et al. (2009). Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect, 117:639-644.
Calderon-Margalit R, Friedlander Y, Yanetz R, et al. (2009). Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol, 169:365-375.
Cal-EPA: California Environmental Protection Agency (2005). Proposed identification of environmental tobacco smoke as a toxic air contaminant. www.oehha.ca.gov/air/environmental_tobacco/pdf/app3partb2005.pdf (7/12/2010).
Calle EE, Miracle-McMahill HL, Thun MJ, et al. (1994). Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol, 139:1001-1007.
Cameron HL, Foster WG (2009). Developmental and lactational exposure to dieldrin alters mammary tumorigenesis in her2/neu transgenic mice. Plos One, 4:e4303.
Cantor KP, Stewart, PA, Brinton LA, et al. (1995). Occupational exposures and female breast cancer mortality in the United States. J Occup Environ Med, 37:336-348.
Carey LA, Perou CM, Livasy CA, et al. (2006). The poor prognosis basal-like breast cancer subtype is over-represented in young African-American women. J Am Med Assoc, 7:2492-2502.
Carpenter DO (2010). Electromagnetic fields and cancer: The cost of doing nothing. Rev Envir Health, 25:75-80.
Carwile JL, Luu HT, Bassett LS, et al. (2009). Polycarbonate use and urinary bisphenol A concentrations. Environ Health Perspect, 117:1368-1372.
Cassidy RA, Natarajan S, Vaughan GM (2005). The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat, 90: 55-64.
CDC: Center for Disease Control and Prevention. (2005). Third National Report on Human Exposure to Environmental Chemicals. Atlanta: Centers for Disease Control and Prevention.
CDC: Center for Disease Control and Prevention. (2007). Decline in breast cancer incidence: United States, 1999-2003. Morbid Mortal Weekly Rep, 56: 549-553.
CDC: Center for Disease Control and Prevention. (2009). Fourth national report on human exposure to environmental chemicals. Atlanta: Centers for Disease Control and Prevention.
CDPH: California Department of Public Health (2010). California safe cosmetics program. www.cdph.ca.gov/programs/cosmetics/Pages/default.aspx (7/12/2010).
CEC: Commission of the European Communities (2004). Commission staff working document on implementation of the community strategy for endocrine disruptors: a range of substances suspected of interfering with the hormone systems of humans and wildlife. http://ec.europa.eu/environment/endocrine/documents/sec_2004_1372_en.pdf (7/12/2010).
Cederroth CR, Nef S (2009). Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol, 304:30-42.
CEPA: CEPA Environmental Registry (2009). Consultation document phenol, 4,4’-(1-methylethylidene)bis-(bisphenol A). www.ec.gc.ca/ceparegistry/documents/participation/pba/p3.cfm (7/12/2010).
CGHFBC: Collaborative Group on Hormonal Factors in Breast Cancer (1996). Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet, 347:1713-1727.
CGHFBC: Collaborative Group on Hormonal Factors in Breast Cancer (1997). Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 350:1047-1059.
Chan MM, Lu X, Merchant FM, Iglehart JD, Miron PL (2005). Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. Carcinogenesis, 26:1343-1353.
Chang YM, Tai CF, Lin RS, et al. (2003). A proportionate cancer morbidity ratio study of workers exposed to chlorinated organic solvents in Taiwan. Ind Health, 41:77-87.
Charlier CJ, Albert AI, Zhang L, et al. (2004). Polychlorinated biphenyls contamination in women with breast cancer. Clin Chim Acta, 347:177-181.
Chen C, Ma X, Zhong M, Yu Z (2010). Extremely low-frequency electromagnetic fields exposure and females breast cancer risk: a meta-analysis based on 24,338 cases and 60,628 controls. Breast Cancer Res Treat, doi:10.1007/s10549-010-0782-6.
Chen JW, Wang SL, Y HY, et al. (2006). Body burden of dioxins and dioxin-like polychlorinated biphenyls in pregnant women residing in a contaminated area. Chemosphere, 65: 1667-1677.
Chen Z-B, An Y, Wang Z, et al. (2007). Tobacco-specific carcinogen 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) activating ERK1/2 MAP kinases and stimulating proliferation of human mammary epithelial cells. Chem Res Chin Univ, 23:76-80.
Chiam K, Tilley W, Butler L, Bianco-Miotto T (2009). The dynamic and static modification of the epigenome by hormones: A role in the developmental origin of hormone related cancers. Biochim Biophys Acta, 1795:104-109.
Chiazze L Jr., Ference LD (1981). Mortality among PVC fabricating employees. Environ Health Perspect, 41:137-143.
CHNSC: California Healthy Nail Salon Collaborative (2010a). Framing a proactive research agenda to advance worker health and safety in the nail salon and cosmetology communities. http://saloncollaborative.files.wordpress.com/2009/03/collab_researchrpt_final.pdf (7/12/2010).
CHNSC: California Healthy Nail Salon Collaborative (2010b). Do you work in a nail salon? Brochure.
Choi AL, Levy JI, Dockery DW, et al. (2006). Does living near a Superfund site contribute to higher polychlorinated biphenyl (PCB) exposure? Environ Health Perspect, 114:1092-1098.
Chou YY, Huang PC, Lee CC, et al. (2009). Phthalate exposure in girls during early puberty. J Pediatr Endocrinol Metab, 22:69-77.
Clavel-Chapelon F and the E3N-EPIC Group (2002). Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer, 86:723-727.
Clemons MM, Loijens L, Goss P (2000). Breast cancer risk following irradiation for Hodgkin’s disease. Cancer Treat Rev, 26:291-300.
Cohn BA, Wolff MA, Cirillo PM, et al. (2007). DDT and breast cancer in young women: New data on the significance of age at exposure. Environ Health Perspect, 115:1406-1414.
Colditz GA, Hankinson SE, Hunter DJ, et al. (1995). The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med, 332:1589-1593.
Collier RJ, Miller MA, Hildebrandt JR, et al. (1991). Factors affecting insulin-like growth factor-I concentration in bovine milk. J Dairy Sci, 74:2095-2911.
Collier RJ, Miller MA, McLaughlin CL, et al. (2008). Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows. Domest Anim Endocrinol, 35:16-23.
Collins JJ, Bodner K, Burns CJ, et al. (2007). Body mass index and serum chlorinated dibenzo-p-dioxin and dibenzofuran levels. Chemosphere, 66:1079-1085.
Colton T, Greenberg ER, Noller K, et al. (1993). Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. J Am Med Assoc, 269:2096-2100.
Conde J, Silva SN, Azevedo AP, et al. (2009). Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study. BioMed Cent, 9:344.
Connor K, Ramamoorthy K, Moore M, et al. (1997). Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: Structure-activity relationships. Toxicol Appl Pharmacol, 145:111-123.
Constantinou AI, White BE, Tonetti D, et al. (2005). The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumors. Eur J Cancer, 41:647-654.
Coogan PF, Clapp RW, Newcomb PA, et al. (1996). Occupational exposure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology, 7:459-464.
Cooper RL, Stoker TE, Tyrey L, et al. (2000). Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci, 53:297-307.
Cos S, Sanchez-Barcelo EJ (2000). Melatonin and mammary pathological growth. Front Neuroendocrinol, 21:133-170.
Costa G, Haus E, Stevens R (2010). Shift work and cancer: considerations on rationale, mechanisms, and epidemiology. Scand J Environ Health, 36:163-179.
Costa LG, Giordano G (2007). Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants. Neurotoxicology, 28:1047-1067.
Costa LG, Giordano G, Tagliaferri S, et al. (2008). Polybrominated diphenyl ether (PBDE) flame retardants: environmental contamination, human body burden and potential adverse health effects. ACTA Biomed, 79:172-183.
Costantini AS, Gorini G, Consonni D, et al. (2009). Exposure to benzene and risk of breast cancer among shoe factory workers in Italy. Tumori, 95:8-12.
Courtney D, Sandau CD, Ayotte P (2000). Analysis of hydroxylated metabolites of PCBs (OH-PCBs) and other chlorinated phenolic compounds in whole blood from Canadian Inuit. Environ Health Perspect, 108:611-616.
CPIC: Cancer Prevention Institute of California (2010). Breast cancer risks in California nail salon workers. www.cpic.org/site/apps/nlnet/content3.aspx?c=skI0L6MKJpE&b=5730937&ct=7811371¬oc=1 (7/12/2010).
CPSC: Consumer Product Safety Commission (2009). CPSIA: Section 108. Products containing certain phthalates. www.cpsc.gov/about/cpsia/sect108.html (7/12/2010).
Cui Y, Miller AB, Rohan TE (2006). Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat, 100:293.
Curl CL, Fenske RA, Elgethun K (2003). Organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets. Environ Health Perspect, 111:377-82.
Curwin BD, Hein MJ, Sanderson WT, et al. (2005). Pesticide contamination inside farm and nonfarm homes. J Occup Environ Hygiene, 2:357-367.
D
Daewood S, Cristofanilli M (2007). What progress have we made in managing inflammatory breast cancer? Oncology, 21:673-685.
Dai Q, Liu B, Du Y (2009). Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use. Front Med China, doi:10.1007/s11685-009-0080-z.
Dairkee SH, Seok J, Champion S, et al. (2008). Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res, 68:2076-2080.
Darbre PD, Aljarrah A, Miller WR, et al. (2004). Concentrations of parabens in human breast tumours. J Appl Toxicol, 24:5-13.
Darbre PD, Harvey PW (2008). Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase, and discussion of possible health risks. J Appl Toxicol, 28:561-578.
Darnerud PO, Eriksen GS, Johannesson T, et al. (2001). Polybrominated diphenyl ethers. Occurance Dietary Toxicol Environ Health Perspect, 109 (Suppl 1):49-68.
Davis DL, Bradlow HL, Wolff M et al. (1993). Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environ Health Perspect, 101:371-377.
Davis FB, Lin H-Y, Luidens MK, et al. (2009). Similar and shared nongenomic mechanisms of action of estrogen and thyroid hormone. Immunol Endocr Metab Agents Med Chem, 9:84-89.
Davis S (2009). Benzene: CEH marketing research report abstract. Chemical Industries Newsletter. www.sriconsulting.com/CEH/Public/Reports/452.0000/ (7/12/2010).
Daxenberger A, Breier BH, Sauerwein H (1998). Increased milk levels of insulin-like growth factor 1 (IGF-1) for the identification of bovine somatotropin (bST) treated cows. Analyst, 123: 2429-2435.
DeBruin LS, Josephy PD (2002). Perspectives on the chemical etiology of breast cancer. Environ Health Perspect, 110:119-128.
DeBruin LS, Pawliszyn JB, Josephy PD (1999). Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk. Chem Res Toxciol, 12:78-82.
Decastro BR, Korrick SA, Spengler JD, et al. (2006). Estrogenic activity of polychlorinated biphenyls present in human adipose tissue and the environment. Environ Sci Technol, 40:2819-2825.
De Hond E, Schoeters G (2006). Endocrine disruptors and human puberty. Int J Androl, 29:264-271.
del Valle J, Feliubadalo L, Nadal M et al. (2009). Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat, doi:10.1007/s10549-009-0613-9.
Delort L, Kwiatkowski F, Chalabi N, et al. (2007). Risk factors for early age at breast cancer onset: The “COSA Program” population based study. Anticancer Res, 27:1087-1094.
de los Santos JF, Buchholz TA (2000). Carcinogenesis of the male breast. Curr Treat Options Oncol, 1:221-227.
de Vocht F, Sobala W, Wilczynska U, et al. (2009). Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland. Cancer Epidemiol, 33: 94-102. De Wit CA. (2002). An overview of brominated flame retardants in the environment. Chemosphere, 46:583-624.
Dewan MZ, Ahmed A, Iwasaki Y, et al. (2006). Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed & Pharmacother, 60:273-276.
Diamanti-Kandarakis E et al. (2009). Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr Rev, 30:293-342.
Dich J, Zahm SH, Hanberg A, et al. (1997). Pesticides (heptachlor) and cancer. Cancer Causes Control, 8:420-443.
Dip R, Buterin T, Wenger D, et al. (2008). Genetic reprogramming of human mammary cells by environmental carcinogens released into breast milk. Chimia, 62:410-416.
Dip R, Lenz S, Gmuender H, Naegeli H (2009). Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol, 47:787-795.
Donovan M, Tiwary CM, Axelrod D, et al. (2007). Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses, 68:756-766.
Dosemeci M, Blair A (1994). Occupational cancer mortality among women employed in the telephone industry. J Occup Med, 36:1204-1209.
dos Santos Silva I, Wark PA, McCormack VA et al. (2009). Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer, 100:1824-1831.
Draelos ZD (2005). Topical and oral estrogens revisited for antiaging purposes. Fertil Steril, 84:291-292.
Drost RM, Jonkers J (2009). Preclinical mouse models for BRCA1–associated breast cancer. Br J Cancer, 101:1651-1657.
Dumeaux V, Borresen-Dale A-L, Frantzen J-O, et al. (2008). Gene expression analyses in breast cancer epidedemiology: The Norwegian women and cancer postgenome cohort study. Breast Cancer Res, 10. http://breast-cancer-research.com/content/10/1/R13 (7/12/2010).
Dumitrescu RG, Cotarla I (2007). Understanding breast cancer risk: where do we stand in 2005? J Cell Mol Med, 9:208-221.
Duran-Alvarez JC, Becerril-Bravo E, Castro VS, et al. (2009). The analysis of a group of acidic pharmaceuticals, carbamazepine, and potential endocrine disrupting compounds in wastewater irrigated soils by gas chromatography-mass spectrometry. Talanta, 78:1159-1166.
Durando M, Kass L, Piva J, et al. (2007). Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect, 115:592-598.
Durmaz E, Ozmert EN, Erkekoglu P, et al. (2010). Plasma phthalate levels in pubertal gynecomastia. Pediatrics, 125:e122-e129.
Dworkin AM, Huang THM, Toland AE (2009). Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol, 19:165-171.
E
Eaton ML (2004) Ethics analysis applied to Monsanto and the labeling of rBST. In: Ethics and the Business of Bioscience, pp. 70-105. Palo Alto, CA: Stanford University Press.
EBCTCG: Early Breast Cancer Trialists’ Collaborative Group (2000). Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet, 355:1757-1770.
EC: European Commission (1985). Council Directive 85/469/EEC, Council Directive prohibiting the use in livestock farming of certain substances having hormonal action. Official Journal No L 382, 31 12 1985, pp. 228-231 http://eur-lex.europa.eu/LexUriServ/LexUriServdo?uri=CELEX:31996L0023:EN:HTML (7/12/2010).
EC: European Commission, Health & Consumer Protection Directorate General (2002). Opinion of the scientific committee on veterinary measures relating to public health. Review of previous SCVPH opinions of 30 April 1999 and 3 May 2000 on the potential risks to human health from hormone residues in bovine meat and meat products. http://ec.europa.eu/food/fs/sc/scv/out50_en.pdf (7/12/2010).
EC: European Commission, Enterprise and Industry Directorate General (2008). Consumer goods: Cosmetics. Consolidated version of cosmetics directive 76/768/EEC. http://ec.europa.eu/enterprise/cosmetics/html/consolidated_dir.htm (7/12/2010).
El-Gamal H, Bennett RG (2006). Increased breast cancer risk after radiotherapy for acne among women with skin cancer. J Am Acad Dermatol, 55:981-989.
Engel LS, Hill DA, Hoppin JA, et al. (2005). Pesticide use and breast cancer risk among farmers’ wives in the Agricultural Health Study. Am J Epidemiol, 161:121-135.
Engel SM,. Levy MB, Liu Z, Kaplan D, Wolff MS. (2006). Xenobiotic phenols in early pregnancy amniotic fluid. Reprod Toxicol, 21:110-2.
Enoch RR, Stanko JP, Greiner SN, et al. (2007). Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environ Health Perspect, 115:541-547.
EP: European Parliament. (2009). MEPs approve pesticide legislation. www.europarl.europa.eu/news/expert/infopress_page/066-45937-012-01-03-911-20090112IPR45936-12-01-2009-2009-false/default_en.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (1970). Summary of the Clean Air Act. www.epa.gov/lawsregs/laws/caa.html (7/12/2010).
EPA: U.S. Environmental Protection Agency (1972). Summary of the Clean Water Act. www.epa.gov/lawsregs/laws/cwa.html (7/12/2010).
EPA: U.S. Environmental Protection Agency (1974; 1996). Safe Drinking Water Act. www.epa.gov/safewater/sdwa/ (7/12/2010).
EPA: U.S. Environmental Protection Agency (1998). Chemical hazard data availability study. www.epa.gov/hpv/pubs/general/hazchem.pdf (7/12/2010).
EPA: U.S. Environmental Protection Agency (2003). Health assessment of 1,3-Butadiene. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=54499 (7/12/2010).
EPA: U.S. Environmental Protection Agency (2005a). Understanding radiation: Gamma rays. www.epa.gov/radiation/understand/gamma.html (7/12/2010).
EPA: U.S. Environmental Protection Agency (2005b). EPA Office of Compliance sector notebook project. Profile of the rubber and plastics industry, 2nd Edition. www.epa.gov/compliance/resources/publications/assistance/sectors/notebooks/rubplasn.pdf (7/12/2010).
EPA: U.S. Environmental Protection Agency (2007a). Overview: Office of pollution prevention and toxics programs. www.epa.gov/oppt/pubs/oppt101c2.pdf (7/12/2010).
EPA: U.S. Environmental Protection Agency (2007b). Protecting the health of nail salon workers. www.epa.gov/dfe/pubs/projects/salon/nailsalonguide.pdf (7/12/2010).
EPA: U.S. Environmental Protection Agency (2008a). Atrazine: Third report of the hazard identification assessment review committee. Office of Pesticide Programs. www.epa.gov/pesticides/factsheets/atrazine_background.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (2008b). Bisphenol a. (CASRN 80-05-7). Integrated risk information system (IRIS). www.epa.gov/iris/subst/0356.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (2008c). Data requirements for pesticide registration. http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=013b05537f6069487ae3f2252ae1d5a0&rgn=div5&view=text&node=40:23.0.1.1.9&idno=40#40:23.0.1.1.9.6.1.1 (7/12/2010).
EPA: U.S. Environmental Protection Agency (2009a). Common wastes and materials: Plastics. www.epa.gov/osw/conserve/materials/plastics.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (2009b). Rulemaking underway related to disclosure of all pesticide ingredients. www.epa.gov/opprd001/inerts/ (7/12/2010).
EPA: U.S. Environmental Protection Agency (2010a). Dioxins and furans. www.epa.gov/pbt/pubs/dioxins.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (2010b). Label Review Manual. Chapter 3: General labeling requirements. www.epa.gov/oppfead1/labeling/lrm/chap-03.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (2010c). Endocrine disruptor screening program (EDSP). www.epa.gov/endo/ (7/12/2010).
EPA: U.S. Environmental Protection Agency (2010d). What is the TSCA chemical substance inventory? www.epa.gov/opptintr/newchems/pubs/invntory.htm (7/12/2010).
EPA: U.S. Environmental Protection Agency (2010e). Essential principles for reform of chemicals management Legislation. www.epa.gov/oppt/existingchemicals/pubs/principles.html (7/12/2010).
Erren TC (2001). A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics Suppl, 5:S105-119.
Eskenazi B, Warner M, Marks AR, et al. (2005). Serum dioxin concentrations and age at menopause. Environ Health Perspect, 113:858-862.
Euling SY, Herman-Giddens ME, Lee PA, et al. (2008). Examination of U.S. puberty-timing data from 1940 to 1994 for secular trends: Panel findings. Pediatrics, 1221:S172-S191.
EWG: Environmental Working Group (2004). Exposures add up: survey results. www.cosmeticsdatabase.com/research/exposures.php (7/12/2010).
EWG: Environmental Working Group (2005). Body burden 2: The pollution in newborns. www.ewg.org/reports/bodyburden2 (7/12/2010).
EWG: Environmental Working Group (2009). Pollution in minority newborns. www.ewg.org/minoritycordblood/home (7/12/2010).
EWG: Environmental Working Group (2010). Skin Deep: Cosmetic safety database. www.cosmeticsdatabase.com/ (7/12/2010).
F
Fan WQ, Yanase T, Morinaga H, et al. (2007). Atrazine-induced aromatase expression in SF-1 dependent: Implications for endocrine disruption in wildlife and reproductive cancers in humans. Environ Health Rep, 115:720-727.
Fang H, Tong W, Branham WS, et al. (2003). Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxciol, 16:1338-158.
FDA: U.S. Food and Drug Administration, Partnerships and Collaborations (1976). MOU 225-76-2003: Memorandum of understanding between the U.S. Consumer Product Safety Commission and the U.S. Food and Drug Administration. www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm116207.htm (7/12/2010).
FDA: U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition Organization (1994). Voluntary labeling of milk and milk products from cows that have not been treated with recombinant bovine somatotropin. Interim Guidance. www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/ucm059036.htm (7/12/2010).
FDA: U.S. Food and Drug Administration (2000). Ingredients prohibited & restricted by FDA regulations. www.fda.gov/Cosmetics/ProductandIngredientSafety/SelectedCosmeticIngredients/ucm127406.htm (7/12/2010).
FDA: U.S. Food and Drug Administration, Office of Food Additive Safety (2007). CEDI/ADI database. www.fda.gov/Food/FoodIngredientsPackaging/FoodContactSubstancesFCS/CEDIADIDatabase/default.htm (7/12/2010).
FDA: U.S. Food and Drug Administration. (2008). Draft assessment of bisphenol A for use in food contact applications. www.fda.gov/ohrms/dockets/ac/08/briefing/2008-0038b1_01_02_fda%20bpa%20draft%20assessment.pdf (7/12/2010).
FDA: U.S. Food and Drug Administration (2009). Safety assessment of BPA in medical products. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ScienceBoardtotheFoodandDrugAdministration/UCM176835.pdf (7/12/2010).
FDA: U.S. Food and Drug Administration (2010a). Cosmetics Q&A. www.fda.gov/Cosmetics/ResourcesForYou/Consumers/CosmeticsQA/default.htm (7/12/2010).
FDA: U.S. Food and Drug Administration, Center for Veterinary Medicine (2010b). FDA approved animal drug products. www.accessdata.fda.gov/scripts/animaldrugsatfda/index.cfm?gb=2 (7/12/2010).
FDA: U.S. Food and Drug Administration (2010c). Inventory of effective food contact substance (FCS) notifications. www.cfsan.fda.gov/~dms/opa-fcn.html (7/12/2010).
Fedrowitz M, Kamino K, Loscher W (2004). Significant differences in the effects of magnetic field exposure on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats. Cancer Res, 64:243-251.
Fenton SE (2006). Endocrine-disrupting compounds and mammary gland development: Early exposure and later life consequences. Endocrinology, 147:S18-S24.
Fenton SE, Hamm JT, Birnbaum LS, et al. (2002). Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci, 67:63-74.
Fernandez MF, Molina-Molina JM, Lopez-Espinosa M-J, et al. (2007). Biomonitoring of environmental estrogens in human tissues. Int J Hyg Environ Health, 210:429-432.
Feychting M, Forssen U, Rutqvist LE, et al. (1998). Magnetic fields and breast cancer in Swedish adults residing near high-voltage power lines. Epidemiology, 9:392-397.
Figueiredo JC, Haile RW, Bernstein L, et al. (2010). Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: The WECARE study. Breast Cancer Res Treat, 120:175-183.
Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW (2009). Total visual blindness is protective against breast cancer. Cancer Causes Control, 20:1753-1756.
Foster PM (2005). Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl, 29:140-147.
Foster WG, Younglai EV, Boutross-Tadross O, et al. (2004). Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein. Toxicol Sci, 77: 91-100.
Frederiksen M, Thomsen C, Froshaug M, et al. (2010). Polybrominated diphenyl ethers in paired samples of maternal and umbilical cord blood plasma and associations with house dust in a Danish cohort. Int J Hygiene Environ Health, doi:10.1016/j.ijheh.2010.04.008.
Fromme H, Diemer J, Dietrich S, et al. (2008). Chemical and morphological properties of particulate matter (PM 10, PM 2.5) in school classrooms and outdoor air. Atmospheric Environ, 42:6597-6605.
G
Gaffield ME, Culwell KR, Ravi A (2009). Oral contraceptives and family history of breast cancer. Contraception, 80:372-380.
Gammon MD, Santella RM (2008). PAH, genetic susceptibility and breast cancer risk: an update from the Long Island breast cancer study project. Eur J Cancer, 44:636-640.
Gammon MD, Santella RM, Neugut AI, et al. (2002). Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev, 11:677-685.
Garvin S, Ollinger K, Dabrosin C (2006). Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Sci Direct Cancer Lett, 231:113-122.
Gauthier E, Paoletti X, Clavel-Chapelon F (2004). Breast cancer risk associated with being treated for infertility: results from the French e3n cohort study. Hum Reprod, 19:2216-2221.
Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP (2007). The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene, 26:7916-7920.
Ghoussaini M, Pharoah PDP (2009). Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncol, 5:689-701.
Gierthy JF, Arcaro KF, Floyd M (1997). Assessment of PCB estrogenicity in a human breast cancer cell line. Chemosphere, 34:1495-1505.
Ginsberg GL, Asgharian B, Kimbell JS, Ultman JS, Jarabek AM (2008). Modeling approaches for estimating the dosimetry of inhaled toxicants in children. J Toxicol Environ Health, 71:166-195.
Girgert R, Emons, G Hanf V, Grundker C (2009). Exposure of MCF-7 breast cancer cells to electromagnetic fields up-regulates the plasminogen activator system. Int J Gynecol Cancer, 19: 334-338.
Gitlitz J, Franklin P (2007). Water, Water Everywhere: The Growth of Non-Carbonated Beverages in the United States. Container Recycling Institute. www.container-recycling.org/assets/pdfs/reports/2007-waterwater.pdf (7/12/2010).
Giusti RM, Iwamoto K, Hatch EE. (1995). Diethylstilbestrol revisited: A review of the long-term health effects. Annals Intern Med 122:778-788.
Glass AG, Lacey JV, Carreon JD, et al. (2007). Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152-1161.
Gofman J W (1996). Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of this Disease, 2nd ed.. San Francisco: CNR Book Division, Committee for Nuclear Responsibility.
Gofman JW (1999). Radiation from Medical Procedures in the Pathogenesis of Cancer and Ischemic Heart Disease: Dose-response studies with Physicians per 100,000 Population. San Francisco: CNR Book Division, Committee for Nuclear Responsibility.
Goldberg Z, Lehnert BE (2003). Radiation-induced effects in unirradiated cells: A review and implications in cancer. Int J Oncol, 21:337-349.
Golubicic I, Borojevic N, Pavlovic T (2008). Risk factors for breast cancer: is ionizing radiation among them? J BUON, 13: 487-494.
Gooderham NJ, Creton S, Lauber SN, et al. (2006). Mechanisms of action of the carcinogenic heterocyclic amine PhIP. Toxicol Lett, 168:269-277.
Goodman MT, Shvetsov YB, Wilkens LR, et al. (2009). Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res, 2:887-894.
Goodson WH, Luciani MG, Sayeed A, et al. (2011). Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women. Carcinogenesis. Advance Access Publication. http://carcin.oxfordjournals.org/content/early/2011/09/01/carcin.bgr196.short
Gotzsche P, Hartling O, Nielsen M, et al. (2009). Breast screening: the facts or maybe not. Br Med J, 338: b86.
Goyal R, Khare M (2009). Indoor-outdoor concentrations of RSPM in classroom of a naturally ventilated school building near an urban traffic roadway. Atmospheric Environ, 43:6026-6038.
Gram IT, Braaten T, Terry PD, et al. (2005). Breast cancer among women who started smoking as teenagers. Cancer Epidemiol Biomarkers Prev, 14:61-66.
Graves BA (2008). Integrative literature review: a review of literature related to geographical information systems, healthcare access, and health outcomes. Perspect Health Info Manag, 5:1-13.
Gray LE, Ryan B, Hotchkiss AK, Crofton KM. (2010). Rebuttal of “Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research” by vom Saal. Toxicol Sci, 115:614-620.
Guibout C, Adjadj E, Rubino C, et al. (2005). Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol, 23:197-204.
Guillette LJ, Edwards TM (2008). Environmental influences on fertility: can we learn lessons from studies of wildlife? Am Soc Reprod Med, 89:21-24.
Gwinn MR, Whipkey DL, Tennant LB, Weston A (2007). Gene expression profiling of di-n-butyl phthalate in normal human mammary epithelial cells. J Environ Pathol Toxicol Oncol, 26:51-61.
H
Hagmar L, Wallin E, Vessby B, et al. (2006). Intra-individual variations and time trends 1991-2001 in human serum levels of PCB, DDE, and hexachlorobenzene. Chemosphere, 64:1507-1513.
Haile RW, Thomas DC, McGuire V, et al. (2006). BRCA1 and BRCA2 mutation carriers, oral contraceptive use and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev, 15:1863-1870.
Hanaoka T, Yamamoto S, Sobue T et al. (2005). Active and passive smoking and breast cancer risk in middle-aged Japanese women. Int J Cancer, 114:317-322.
Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005). Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute. J Nat Cancer Inst, 95:966-975.
Hankinson S, Willett WC, Colditz GA, et al. (1998). Circulating concentrations of insulin-like growth factor 1 and risk of breast cancer. Lancet, 351:1393-1396.
Hanrahan C (2000). CRS Report for Congress: RS20142: The European Union’s ban on hormone-treated meat. www.ncseonline.org/NLE/CRSreports/Agriculture/ag-63.cfm (7/12/2010).
Hansen J (1999). Breast cancer risk among relatively young women employed in solvent-using industries. Am J Ind Med, 36:43-47.
Hansen J (2000). Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med, 37:349-352.
Hatakeyama M, Matsumura F (1999). Correlation between the activation of Neu tyrosine kinase and promotion of foci formation induced by selected organochlorine compounds in the MCF-7 model system. J Biochem Mol Toxicol, 13:296-302.
Hayden CG, Roberts MS, Benson HA (1997). Systemic absorption of sunscreen after topical application. Lancet, 350:853-864.
Hayes T, Haston K, Tsui M, et al. (2003). Atrazine-induced hermaphoditism at 0.1 ppb in American leopard frogs (Rana pipiens): Laboratory and field evidence. Environ Health Perspect, 111:568-575.
Health Canada (2008). Health Risk Assessment of Bisphenol A from food packaging applications. Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch.
HCHW: Healthy Child, Healthy World. Chemical encyclopedia: Polybrominated diphenyl ethers (PBDEs). http://healthychild.org/issues/chemical-pop/polybrominated_diphenyl_ethers/ (7/12/2010).
HCWH: Health Care Without Harm. (2002a). Alternatives to polyvinyl chloride (PVC) and di(2-Ethylhexyl) phthalate (DEHP) medical devices. From Going green: A resource kit for pollution prevention in health care. www.noharm.org/lib/downloads/pvc/Alternatives_to_PVC_DEHP.pdf (7/12/2010).
HCWH: Health Care Without Harm. (2002b). Dioxin, PVC, and health care institutions. From Going green: A resource kit for pollution prevention in health care. www.noharm.org/lib/downloads/pvc/Dioxin_PVC_Health_Care.pdf (7/12/2010).
Hecht A, Lee E. (2003). How to fight indoor air pollution. Penton Media. http://nreionline.com/commentary/nmhc/real_estate_fight_indoor_air/ (7/12/2010).
Heiss G, Wallace R, Anderson G, et al. (2008). Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. J Am Med Assoc, 299:1036-1045.
Helferich WG, Andrade JE, Hoagland MS (2008). Phytoestrogens and breast cancer: a complex story. Inflammopharmacol, 16:219-226.
Hemminki K, Li X (2002). Cancer risks in second-generation immigrants to Sweden. Int J Cancer, 99:229-237.
Heneweer M, Muusse M, Dingemans M, et al. (2005). Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci, 83:257-263.
Herbst AL, Scully RE (1970). Adenocarcinoma of the vagina in adolescence. A report of seven cases including six clear cell carcinomas (so-called mesonephromas). Cancer, 25:745-757.
Herbst AL, Ulfelder H, Poskanzer DC (1971). Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. New England J Med, 284:878-881.
Heyes GJ, Mill AJ, Charles MW (2009). Mammography: oncogenecity at low doses. J Radiol Protect, 29:A123-A132.
Hiatt RA, Haslam SZ, Osuch J (2009). The Breast Cancer and the Environment Research Centers: Transdisciplinary research on the role of the environment in breast cancer etiology. Environ Health Perspect, 117:1814-1822.
Hilakivi-Clarke L, de Assis S (2006). Fetal origins of breast cancer. Trends Endocrinol Metab, 17:340-348.
Hildreth NG, Shore RE, Dvoretsky PM (1989). The risk of breast cancer after irradiation of the thymus in infancy. New England J Med, 1989:1281-1284.
Hines EP, Calafat AM, Silva MJ, et al. (2009). Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environ Health Perspect, 117:86-92.
Hines CJ, Nilsen Hopf NB, Deddens JA, et al. (2009). Urinary phthalate metabolite concentrations among workers in selected industries: A pilot biomonitoring study. Ann Occup Hyg, 53:1-17.
Hoffman G (2009). A perspective on the scientific, philosophical, and policy dimensions of hormesis. Dose-Response, 7:1-51.
Holmberg L, Anderson H (2004). HABITS (hormonal replacement therapy after breast cancer—is it safe?) trial stopped. Lancet, 363:453-455.
Homburg R, Insler V (2002). Ovulation induction in perspective. Hum Reprod Update, 8:449-462.
Honma N, Takubo K, Sawabe M, et al. (2007). Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years. J Clin Endocrinol Metab, 607-613.
Hooning M, Aleman B, Hauptmann M, et al. (2007). Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol, 10.1200/JCO.2007.16.0192.
Horner MJ, Ries LAG, Krapcho M, et al. (2009). SEER Cancer Statistics Review, 1975-2006. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al. (2008). The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6:391-401.
Horwich A, Swerdlow AJ (2004). Secondary primary breast cancer after Hodgkin’s disease. Br J Cancer, 90:294-298.
Houle CD, Ton TV, Clayton N, et al. (2006). Frequent p53 and H-ras mutations in benzene- and ethylene oxide-induced mammary gland carcinomas from B6C3F1 mice. Toxicol Pathol, 34:752-762.
Howe GR, McLaughlin J (1996). Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res, 145:694-707.
Hoyer AP, Grandjean P, Jorgensen T, et al. (1998). Organochlorine exposure and risk of breast cancer. Lancet, 352:1816-1820.
Hoyer AP, Jorgensen T, Brock JW, et al. (2000). Organochlorine exposure and breast cancer survival. J Clin Epidemiol, 53:323-330.
Hoyer AP, Gerdes AM, Jorgensen T, et al. (2002). Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat, 71:59-65.
Hsieh CC, Trichopoulos D, Katsouyanni K, et al. (1990). Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study. Int J Cancer, 46:796-800.
Hua WY, Bennett ER, Maio X-S, et al. (2006). Seasonality effects on pharmaceuticals and S-triazine herbicides in wastewater effluent and surface water from the Canadian side of the upper Detroit River. Environ Toxicol Chem, 25:2356-2365.
Huang J, Mackillop WJ (2001). Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer, 92:532-536.
Huff JE, Haseman JK, DeMarini DM, et al. (1989). Multiple-site carcinogenicity of benzene in Fisher 344 rats and B6C3F1 mice. Environ Health Perspect, 82:125-163.
Hunter L, Gadbury GL, Huang Y (2008). Atrazine exposure and breast cancer incidence: an ecologic study of Missouri counties. Toxicol Environ Chem, 90:367-376.
Hwang H-M, Park E-K, Young TM, Hammock BD (2008). Occurrence of endocrine-disrupting chemicals in indoor dust. Sci Total Environ, 404:26-35.
